Inventor · disambiguated record
Stephen Demarest
Also filed as: DEMAREST STEPHEN · DEMAREST STEPHEN J · DEMAREST STEPHEN JOHN
14 granted patents·13 pending applications·197 citations·filing 2005–2023
90Inventor score
Files withLILLY CO ELI16BIOGEN IDEC INC6GLASER SCOTT1HARIHARAN KANDASAMY1PROGENICS PHARMACEUTICALS NEVA1
Top patents by PatentIndex Score
27 records- 0196US7951918B2Stabilized polypeptide compositionsBIOGEN IDEC INC·Filed 2007·Granted May 31, 2011·96 cites·52 claims
- 0294US7612178B2Anti-IGF-1R antibodies and uses thereofBIOGEN IDEC INC·Filed 2007·Granted Nov 3, 2009·24 cites·16 claims
- 0393US8147829B2Anti-IGR-1R antibodies and uses thereofHARIHARAN KANDASAMY·Filed 2009·Granted Apr 3, 2012·41 cites·22 claims
- 0491US10047167B2Methods for producing fabs and bi-specific antibodiesLILLY CO ELI·Filed 2014·Granted Aug 14, 2018·18 cites·21 claims
- 0588US7960142B2Stabilized polypeptide compositionsBIOGEN IDEC INC·Filed 2007·Granted Jun 14, 2011·16 cites·54 claims
- 0671US11820828B2Methods for producing fabs and IgG bispecific antibodiesLILLY CO ELI·Filed 2017·Granted Nov 21, 2023·1 cites·34 claims
- 0768US2024043552A1Methods for Producing Fabs and IgG Bispecific AntibodiesLILLY CO ELI·Filed 2023·Application pending·0 cites
- 0864US10562982B2Methods for producing Fabs and bi-specific antibodiesLILLY CO ELI·Filed 2019·Granted Feb 18, 2020·0 cites·12 claims
- 0964US2025110134A1Stabilized Single Immunoglobulin Variable DomainsTENTARIX BIOTHERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1062US11319370B2CD200R agonist antibodies and uses thereofLILLY CO ELI·Filed 2019·Granted May 3, 2022·0 cites·14 claims
- 1160US10294307B2Methods for producing fabs and bi-specific antibodiesLILLY CO ELI·Filed 2018·Granted May 21, 2019·0 cites·13 claims
- 1259US2022251198A1Cd200r agonist antibodies and uses thereofLILLY CO ELI·Filed 2022·Application pending·0 cites
- 1357US8892364B2Stabilized polypeptide compositionsGLASER SCOTT·Filed 2007·Granted Nov 18, 2014·1 cites·22 claims
- 1457US2009155255A1Cd23 binding molecules and methods of use thereofBIOGEN IDEC INC·Filed 2008·Application pending·0 cites
- 1555US11976136B2IgG bispecific antibodies and processes for preparationLILLY CO ELI·Filed 2020·Granted May 7, 2024·0 cites·10 claims
- 1652US2009087478A1Orally Deliverable and Anti-Toxin Antibodies and Methods for Making and Using ThemPROGENICS PHARMACEUTICALS NEVA·Filed 2005·Application pending·0 cites
- 1751US2022306720A1Proteins comprising t-cell receptor constant domainsLILLY CO ELI·Filed 2020·Application pending·0 cites
- 1850US2022396619A1Cd200 receptor antagonist binding moleculesLILLY CO ELI·Filed 2020·Application pending·0 cites
- 1950US2009130105A1Compositions that bind multiple epitopes of igf-1rBIOGEN IDEC INC·Filed 2008·Application pending·0 cites
- 2050US2009092614A1Anti-IGF-1R Antibodies and Uses ThereofBIOGEN IDEC INC·Filed 2008·Application pending·0 cites
- 2149US11939381B2Bispecific antibodies targeting immune checkpointsLILLY CO ELI·Filed 2019·Granted Mar 26, 2024·0 cites·20 claims
- 2248US10774156B2IgG bispecific antibodies and processes for preparationLILLY CO ELI·Filed 2016·Granted Sep 15, 2020·0 cites·10 claims
- 2347US2024132626A1Fab-Based Trispecific AntibodiesLILLY CO ELI·Filed 2019·Application pending·0 cites
- 2445US2015183877A1Multi-Specific IgG-(Fab)2 Constructs Containing T-Cell Receptor Constant DomainsLILLY CO ELI·Filed 2013·Application pending·0 cites
- 2543US10577415B2Anti-CGRP/anti-IL-23 bispecific antibodies and uses thereofLILLY CO ELI·Filed 2018·Granted Mar 3, 2020·0 cites·15 claims
- 2642US2012100140A1Stabilized fc polypeptides with reduced effector function and methods of useREYES CHRISTOPHER L·Filed 2010·Application pending·0 cites
- 2741US2019040156A1ANTI-TNF- / ANTI-IL-23 IgG BISPECIFIC ANTIBODIESLILLY CO ELI·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →